The Builder's Remedy is a ledger: what Beverly Hills paid to find out

Here is a number that should be taught in every city attorney's office in California: 185.

That is how many units were added to the proposal at 125-129 South Linden Drive in Beverly Hills between the version the city refused to process and the version it is processing now. The original Builder's Remedy application was 19 stories and 165 units, with 33 affordable, plus a 73-room hotel. The amended application, filed within weeks of the developer's courtroom win, is 36 stories and 350 units, with 61 affordable, plus an 80-room luxury hotel. Nearly double the footprint, on the same parcel, against a city that now has materially less legal room to say no.

The Builder's Remedy is usually described as a loophole. That undersells it. It behaves like a ledger. Every month of municipal resistance gets booked somewhere, and in Beverly Hills the entries only ever landed on one side. Walk through the Linden Drive record and you can watch the accounting happen in real time.

What did refusing to process actually cost?

Beverly Hills' opening position was not to deny the Linden application. It was to refuse to process it at all while challenging the developer's entitlement to use the provision. That distinction matters, because a denial engages the merits and a refusal engages the clock.

The clock turned out to be expensive. A non-profit housing-law enforcement group sued the city in June 2024. The developer entity, affiliated with Leo Pustilnikov, filed its own suit in September 2024. The Los Angeles Superior Court consolidated the two matters, and on August 12, 2025, Judge Kin ruled that Beverly Hills violated state housing law by refusing to process the application. The city had to proceed with the 19-story proposal. It convened in closed session, reviewed its options, and found the cupboard bare.

Then came the amendment, and this is where the ledger metaphor stops being decorative. The case file's arithmetic is blunt: roughly 18 months of litigation carry, spread across 185 additional units, cuts the per-unit cost of the fight by more than half. The developer did not merely survive the city's resistance. The developer monetized it. The bigger project keeps its 61 affordable units, which maintains Builder's Remedy eligibility while layering on state density incentives.

Delay bought density. That sentence is the whole case.

Why did the second fight end differently?

The Linden ruling changed the legal weather for everything that came after it, and what happened next at 8844 Burton Way shows a city learning to read its own ledger.

Crescent Heights, Inc. had submitted a 26-story, 200-unit Builder's Remedy application at Burton Way in 2024, with 22 deed-restricted lower-income units, 11% of the total. The Planning Commission was not ready to surrender the merits. On October 21, 2025, it voted 4-1 to have staff prepare a denial resolution on three grounds: the project's separation of affordable units from market-rate units, health and safety code concerns, and fire risk. On November 5, it finalized the denial. Two months after a judge told this city it could not stonewall the Linden project, its commission denied the next one anyway.

The appeal is where the institutional learning shows. Crescent Heights argued the commission was prohibited from denying the project under the Housing Accountability Act, and here is the remarkable part: the city attorney's review and the staff assessment agreed with the developer. Under the HAA, a qualifying housing project can be denied only on specific, objective, written standards. Design-level objections about where the affordable units sit generally do not qualify. Health and safety grounds require a specific written finding, supported by a preponderance of evidence, that denial is necessary to avoid a specific adverse impact that cannot be mitigated. Staff review concluded the record did not support findings at the level the statute demands.

On March 24, 2026, the Beverly Hills City Council granted the appeal and overturned its own Planning Commission. The project moved into processing without anyone needing to sue.

The affordable-unit arithmetic deserves a beat of its own, because it is the machinery under both files. Burton Way qualified with 22 deed-restricted lower-income units out of 200. Linden's original application carried 33 affordable units; the amended 350-unit version carries 61, which keeps Builder's Remedy eligibility intact while stacking state density incentives on top. The affordable set-aside is not a concession in these deals. It is the key that turns the statute on, and sponsors size it deliberately.

And the Linden ruling did not stay confined to one parcel. The record describes it being cited in subsequent Beverly Hills Builder's Remedy approvals through late 2025 and early 2026, and as persuasive authority in the Burton Way appeal itself, as the city adjusted its posture to the ruling's legal reality. One consolidated case recalibrated an entire city's processing behavior.

Read the two outcomes side by side. Linden: resist procedurally and lose in court, then watch the tower double. Burton Way: deny on the merits, then reverse yourself in public session once your own attorneys read the statute. The council's reversal was the cheaper path precisely because the Linden entry was already on the books; the ruling was being cited in subsequent Beverly Hills Builder's Remedy approvals and as persuasive authority in the Burton Way appeal itself.

What does the ledger mean beyond Beverly Hills?

For cities, the lesson is uncomfortable but simple: under the current statutory regime, resistance to a qualifying Builder's Remedy project is not a strategy, it is a purchase. The city buys months, and it pays in negotiating position. Every procedural obstacle that fails in court strengthens the developer's position past what timely processing would have produced. A commission that wants to shape a project has exactly one cheap window, early, in processing, where design input is negotiation rather than defiance.

For developers and capital, the Beverly Hills files reprice the asset. A Builder's Remedy application in a non-compliant jurisdiction is not a coin flip on whether the city cooperates. It is closer to an option whose value increases with municipal resistance, provided the sponsor can carry the litigation. Not every sponsor can; 18 months of carry is real money, and the record here settled nothing about how a court would treat weaker facts. The legal hedge belongs in the underwriting. But the direction of the asymmetry, on this record, is not ambiguous.

One caution before anyone gets carried away: none of this means the towers are built. Linden holds an amended application, Burton Way is in processing, and multifamily entitlement has plenty of downstream failure modes that a Builder's Remedy win does not erase. The ledger tracks negotiating power, not certificates of occupancy.

My call: Beverly Hills does not finalize another Builder's Remedy denial that survives appeal in 2026, because its own attorneys have now read the HAA into the record twice. More broadly, I expect "delay-bought density" to show up as an explicit strategy in sponsor memos within the year; the Linden math is too clean not to imitate. What would prove me wrong is a California city winning a refuse-to-process fight on the merits this cycle. I have not found that case yet, and I have been looking.

This analysis is a source-cited research summary drawn from public records, not legal advice. It can contain errors and should be verified independently before any investment decision.